Cargando…

Correction: Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease

Detalles Bibliográficos
Autores principales:	Liu, Yang, Guo, Yubo, An, Sai, Kuang, Yuyang, He, Xi, Ma, Haojun, Li, Jianfeng, Lu, Jing, Zhang, Ning, Jiang, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765454/ http://dx.doi.org/10.1371/annotation/5f08fe1e-8868-421c-92ea-1a4aa987d11f

Ejemplares similares

Targeting Caspase-3 as Dual Therapeutic Benefits by RNAi Facilitating Brain-Targeted Nanoparticles in a Rat Model of Parkinson’s Disease
por: Liu, Yang, et al.
Publicado: (2013)

Retraction Note: RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cells
por: Wang, Tao, et al.
Publicado: (2019)

A choline derivate-modified nanoprobe for glioma diagnosis using MRI
por: Li, Jianfeng, et al.
Publicado: (2013)

Identification of Allele-Specific RNAi Effectors Targeting Genetic Forms of Parkinson's Disease
por: Sibley, Christopher R., et al.
Publicado: (2011)

Correction: Attentional Control via Parallel Target-Templates in Dual-Target Search
Publicado: (2014)

Correction to: Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria
por: Badri, Prajakta, et al.
Publicado: (2022)

Lentiviral-mediated RNAi targeting caspase-3 inhibits apoptosis induced by serum deprivation in rat endplate chondrocytes in vitro
por: Ding, L., et al.
Publicado: (2014)

Correction: Calpain and Reactive Oxygen Species Targets Bax for Mitochondrial Permeabilisation and Caspase Activation in Zerumbone Induced Apoptosis
por: Sobhan, Praveen K., et al.
Publicado: (2022)

Nanoparticle-Based RNAi Therapeutics Targeting Cancer Stem Cells: Update and Prospective
por: Tang, Yongquan, et al.
Publicado: (2021)

Author Correction: PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma
por: Cai, Chenlei, et al.
Publicado: (2020)

Caspases as therapeutic targets
por: Howley, B, et al.
Publicado: (2008)

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
por: Davis, Mark E., et al.
Publicado: (2010)

Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract
por: Zhang, Yuan, et al.
Publicado: (2022)

iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis
por: Egorova, Anna, et al.
Publicado: (2023)

Carboxylesterase-Cleavable Biotinylated Nanoparticle for Tumor-Dual Targeted Imaging
por: Chen, Peiyao, et al.
Publicado: (2019)

Nanoparticles as Drug Delivery Systems of RNAi in Cancer Therapy
por: Li, Diedie, et al.
Publicado: (2021)

Correction: Gene therapy in Parkinson's disease: targeting the endoplasmic reticulum proteostasis network
Publicado: (2015)

Correction: Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
por: Lee, Jihoon, et al.
Publicado: (2023)

Correction: Dual-targeting of Arabidopsis DMP1 isoforms to the tonoplast and the plasma membrane
Publicado: (2017)

RNAi off-targeting: Light at the end of the tunnel
por: Brown, Kirk, et al.
Publicado: (2006)

Dual targeting nanoparticles for epilepsy therapy
por: Hou, Qinghong, et al.
Publicado: (2022)

A genome-wide RNAi screen reveals multiple regulators of caspase activation
por: Yi, Caroline H., et al.
Publicado: (2007)

Correction to: miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s disease
por: Liu, Xiaoting, et al.
Publicado: (2019)

The protein kinase TOUSLED facilitates RNAi in Arabidopsis
por: Uddin, Mohammad Nazim, et al.
Publicado: (2014)

Correction: An RNAi-Based Approach to Down-Regulate a Gene Family In Vivo
por: Kim, Jeehee, et al.
Publicado: (2013)

Correction: The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis
por: Zhong, Rui, et al.
Publicado: (2019)

Targeting SOD1 via RNAi with PEGylated graphene oxide nanoparticles in platinum-resistant ovarian cancer
por: Szénási, Attila, et al.
Publicado: (2023)

Correction to: Hsa_circ_0001361 facilitates the progress of lung adenocarcinoma cells via targeting miR-525-5p/VMA21 axis
por: Shen, Hong-Yu, et al.
Publicado: (2021)

Application of RNAi to Genomic Drug Target Validation in Schistosomes
por: Guidi, Alessandra, et al.
Publicado: (2015)

Mosquito gene targeted RNAi studies for vector control
por: Yadav, Mahima, et al.
Publicado: (2023)

Correction: Impact of disease stage and age at Parkinson’s onset on patients’ primary concerns: Insights for targeted management
por: Bhidayasiri, Roongroj, et al.
Publicado: (2021)

Correction: The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
por: Amendola, Alessandra, et al.
Publicado: (2020)

Correction: RNAi-mediated knockdown of daf-12 in the model parasitic nematode Strongyloides ratti
por: Dulovic, Alex, et al.
Publicado: (2020)

Correction: Neurovascular injury associated non-apoptotic endothelial caspase-9 and astroglial caspase-9 mediate inflammation and contrast sensitivity decline
por: Colón Ortiz, Crystal, et al.
Publicado: (2022)

Inhibition by Multifunctional Magnetic Nanoparticles Loaded with Alpha-Synuclein RNAi Plasmid in a Parkinson's Disease Model
por: Niu, Shuiqin, et al.
Publicado: (2017)

Correction: Implementation barriers and facilitators to a COVID-19 intervention in Bangladesh: The benefits of engaging the community for the delivery of the programme
por: Akter, Fahmida, et al.
Publicado: (2023)

Tau and Caspase 3 as Targets for Neuroprotection
por: Idan-Feldman, Anat, et al.
Publicado: (2012)

Correction: Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2
por: Chen, Shanmei, et al.
Publicado: (2022)

Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration
por: Muralidharan, Ranganayaki, et al.
Publicado: (2016)

Correction: A Network of Conserved Damage Survival Pathways Revealed by a Genomic RNAi Screen
por: Ravi, Dashnamoorthy, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4l3fame3pjsoo51a38srj01rbk